Evaluation of a 3D C-Vit Model for Enhanced Grading of Pediatric Brain Tumors: Interpretability and Performance Insights - Top-Institutions - MDSpire

Evaluation of a 3D C-Vit Model for Enhanced Grading of Pediatric Brain Tumors: Interpretability and Performance Insights

  • By

  • Huixin Wu

  • Limeng Zhao

  • Yong Zhang

  • Can Zhang

  • Guohua Zhao

  • Wenjing Li

  • Yangyang Cheng

  • Xinxin Wang

  • Tan Ping

  • Xinyu Wang

  • Fupeng Wei

  • Qian Zhang

  • Jie Dong

  • Weijian Wang

  • April 27, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    St. Jude Children's Research Hospital
    St. Jude Children's Research Hospital

    Memphis, TN

    Key Differentiators

    • Pediatric Neuro-Oncology
    • Neuroradiology
    • Pediatric Neurosurgery

  • #2

    Boston Children's Hospital
    Boston Children's Hospital

    Boston, MA

    Key Differentiators

    • Pediatric Neurosurgery
    • Neuroradiology
    • Neuro-Oncology

  • #3

    Children's Hospital of Philadelphia (CHOP)
    Children's Hospital of Philadelphia (CHOP)

    Philadelphia, PA

    Key Differentiators

    • Pediatric Neuro-Oncology
    • Radiology
    • Neurosurgery

  • #4

    Dana-Farber/Boston Children's Cancer and Blood Disorders Center
    Dana-Farber/Boston Children's Cancer and Blood Disorders Center

    Boston, MA

    Key Differentiators

    • Pediatric Oncology
    • Neuro-Oncology
    • Radiology

  • #5

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Neuro-Oncology
    • Radiology
    • Pediatric Oncology

Original Source(s)

Evaluation of a 3D C-Vit Model for Enhanced Grading of Pediatric Brain Tumors: Interpretability and Performance Insights

  • by Huixin Wu, Limeng Zhao, Yong Zhang, Can Zhang, Guohua Zhao, Wenjing Li, Yangyang Cheng, Xinxin Wang, Tan Ping, Xinyu Wang, Fupeng Wei, Qian Zhang, Jie Dong, Weijian Wang

  • April 27, 2026

Related Content

Case Report: First description of an intracranial “NET” in ROHHAD syndrome; time to rename to the ROHHAD-NeCT syndrome?

Characteristics and risk factors of immune-related adverse events in patients receiving immune checkpoint inhibitor combination therapy

Impact of the clonal architecture and probable biallelic inactivation of TET2 mutations in myelodysplastic neoplasms